1. McIntyre AM. Dynamic competition: research and development. Key issues in the pharmaceutical industry. Chichester: John Wiley & Sons, Ltd, 1999
2. Pilling D. Aventis puts 25% target on growth. Financial Times 2001 Mar 5; Sect. Companies and Finance: 28 (col. 5)
3. Sykes R. Drug firms are not the villains. Financial Times 2001 Mar 11; Sect. Commentary and Analysis: 17 (col. 1-6)
4. Pilling D. Oxfam urges charitable stance on drugs patent. Financial Times 2001 Feb 12; Sect. Europe: 6 (col. 1–8)
5. Essential drugs [online]. Available from URL:
http://www.who.int/aboutwho/en/ensuring/essential.html
[Accessed 2002 May 23]